Supportive Clinic for Patients Living With Advanced and Metastatic Cancers
Launched by THE UNIVERSITY OF HONG KONG · Jun 17, 2024
Trial Information
Current as of August 21, 2025
Not yet recruiting
Keywords
ClinConnect Summary
This clinical trial is looking at how a special supportive care program can help people living with advanced or metastatic cancer. The goal is to see if this program can improve patients' experiences, especially in terms of their physical symptoms and overall quality of life. Researchers want to find out if this program is effective and acceptable, which means they will check how well it works for patients and if they like it.
To participate, you need to be at least 18 years old and have been diagnosed with advanced or metastatic cancer. You should also be able to physically attend the supportive clinic. Unfortunately, if you don’t speak Cantonese, Mandarin, or English, you won’t be able to join this study. While the trial is not yet recruiting participants, those who do take part can expect to engage with a supportive environment designed to help manage their symptoms and improve their well-being.
Gender
ALL
Eligibility criteria
- Inclusion Criteria:
- • Patients diagnosed with advanced or metastatic cancer
- • are at least 18 years of age
- • physically able to attend the supportive clinic.
- Exclusion Criteria:
- • Participants will be excluded from the study if they are non-Cantonese-, non-Mandarin-, or non-English-speakers.
About The University Of Hong Kong
The University of Hong Kong (HKU) is a leading research institution dedicated to advancing medical knowledge and improving healthcare outcomes through innovative clinical trials. With a commitment to excellence in research and education, HKU collaborates with various stakeholders, including healthcare providers and industry partners, to conduct rigorous and ethically sound clinical studies. The university's diverse expertise and state-of-the-art facilities enable it to explore a wide range of therapeutic areas, contributing to the global pursuit of scientific advancement and the development of novel treatment strategies.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Hong Kong, , Hong Kong
Hong Kong, , Hong Kong
Hong Kong, , Hong Kong
Hong Kong, , Hong Kong
Hong Kong, , Hong Kong
Patients applied
Trial Officials
Wendy Lam, Phd
Principal Investigator
School of Public Health, The University of Hong Kong
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported